Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: A retrospective cohort study

Acta Gastro-Enterologica Belgica

Volumn 73, Issue 3, 2010, Pages 336-341

  Maleux, G ^a   Perez Gutierrez, N A ^a   Evrard, S ^b   Mroue, A ^b   Moine, O Le ^b   Laleman, W ^a   Nevens, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Hepatic encephalopathy; Refractory ascites; TIPS*Covered stent

Indexed keywords

BILIRUBIN; POLITEF;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL HYPERTENSION; RETROSPECTIVE STUDY; STENT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; AGED; ASCITES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; STENTS;

EID: 77958462910     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ARROYO V, GINÈS P, GERBES AL, DUDLEY FJ, GENTILINI P, LAFFI G, REYNOLDS TB, RING-LARSEN H, SCHÖLMERICH J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996, 23: 164-176.
2. ARROYO V, COLMENERO J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J. Hepatol. 2003, 38: S69-S89.
3. DELTENRE P, MATHURIN P, DHARANCY S, MOREAU R, BULOIS P, HENRION J, PRUVOT FR, ERNST O, PARIS JC, LEBREC D. Transjugular intrahepatic portosystemic shunt in refractory ascites: a metaanalysis. Liver Int., 2005, 25: 349-356.
4. SALERNO F, CAMMÁ C, ENEA M, RÖSSLE M, WONG F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology, 2007, 133: 825-834
5. LEBREC D, GIUILY N, HADENGUE A, VILGRAIN V, MOREAU R, POYNARD T, GADANO A, LASSEN C, BENHAMOU JP, ERLINGER S. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial French Group of Clinicians and a Group of Biologists. J. Hepatol., 1996, 25: 135-144.
6. RÖSSLE M, OCHS A, GULBERG V, SIEGERSTETTER V, HOLL J, DEIBERT P, OLSCHEWSKI M, REISER M, GERBES AL. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N. Engl. J. Med., 2000, 342: 1701-1707.
7. GINÈS P, URIZ J, CALAHORRA B, GARCIA-TSAO G, KAMATH PS, DEL ARBOL LR, PLANAS R, BOSCH J, ARROYO V, RODÈS J. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology, 2002, 123:1839-1847.
8. ALBILLOS A, BANARES R, GONZALEZ M, CATALINA MV, MOLINERO LM. A meta-analysis of transjugular intrahepatic portosys- temic shunt versus paracentesis for refractory ascites. J. Hepatol., 2005, 43:990-996.
9. ZUCKERMAN DA, DARCY MD, BOCCHINI TP, HILDEBOLT CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am. J. Roentgenol., 1997, 169: 1727-1731.
10. ANGERMAYR B, CEJNA M, KARNEL F, GSCHWANTLER M, KOENIG F, PIDLICH J, MENDEL H, PICHLER L, WICHLAS M, KREIL A, SCHMID M, FERLITSCH A, LIPINSKI E, BRUNNER H, LAMMER J, FERENCI P, GANGL A, PECK-RADOSAVLJEVIC M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intra- hepatic portosystemic shunt. Gut., 2003, 52: 879-885.
11. TER BORG PC, HOLLEMANS M, VAN BUUREN HR, VLEGGAAR FP, GROENEWEG M, HOP WC, LAMÉRIS JS. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. Radiology, 2004, 231: 537-545.
12. SANYAL AJ, GENNING C, REDDY KR, WONG F, KOWDLEY KV, BENNER K, MCCASHLAND T. The North American Study for the Treatment of Refractory Ascites. Gastroenterology, 2003, 124: 634-641.
13. SALERNO F, MERLI M, RIGGIO O, CAZZANIGA M, VALERIANO V, POZZI M, NICOLINI A, SALVATORI F. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology, 2004, 40: 629-635
14. BUREAU C, GARCIA-PAGAN JC, OTAL P, POMIER-LAYRARGUES G, CHABBERT V, CORTEZ C, PERREAULT P, PÉRON JM, ABRALDES JG, BOUCHARD L, BILBAO JI, BOSCH J, ROUSSEAU H, VINEL JP. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology, 2004, 126: 469-475.
15. D'AMICO G, LUCA A, MORABITO A, MIRAGLIA R, D'AMICO M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology, 2005, 129: 1282-1293. (Pubitemid 41446867)
16. MALINCHOC M, KAMATH PS, GORDON FD, PEINE CJ, RANK J, TER BORG PC. A model to predict poor survival in patients undergoing tran- sjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871
17. MONTGOMERY A, FERRAL H, VASAN R, POSTOAK DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent. Radiol., 2005, 28: 307-312
18. MALEUX G, NEVENS F, WILMER A, HEYE S, VERSLYPE C, THIJS M, WILMS G. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur. Radiol, 2004, 14: 1842-1850.
19. MALEUX G, VERSLYPE C, HEYE S, WILMS G, MARCHAL G, NEVENS F. Endovascular shunt reduction in the management of transjugu- lar portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. AJR Am. J. Roentgenol., 2007, 188: 659-664.
20. MALEUX G, HEYE S, VERSLYPE C, NEVENS F. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study. J. Vasc. Interv. Radiol., 2007, 18: 986-992
21. GERBES AL, GULBERG V. Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference. Hepatology, 2005, 41: 217